Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New Devices for Varicose Veins

This article was originally published in Start Up

Executive Summary

There's nothing even remotely sexy about varicose veins. Yet medical device companies and their investors are starting to view the opportunity for treating these bulging blue leg veins as downright alluring. The recent introduction of minimally invasive technologies, combined with shifting demographics and favorable reimbursements, are fueling talk of blockbuster potential for this hybrid clinical/cosmetic market.

You may also be interested in...



Beauty: In the Eye of the Stakeholder

A $12-billion market and growing, the field of aesthetic medicine has exploded with new treatments and techniques for improving and restoring the quality, health and appearance of aging skin. Techniques such as tissue tightening, skin resurfacing, cellulite treatments, dermal augmentation, and fat removal are just some of the new advancements in aesthetic medicine that were highlighted at the 2007 American Academy of Dermatology meeting.

VeinRx Inc.

VeinRx's balloon-controlled venous ablation technology is designed to address both the medical and cosmetic varicose vein markets. It is a single-use, catheter-based product for delivering a sclerosant to the diseased vein. The balloon prevents the chemical from migrating out of the treatment zone. Physicians thus have greater control over both the dosage and the treatment area. There's also a potential safety benefit since the sclerosing agent cannot disperse into the general circulation.

Vascular Insights LLC

Vascular Insights isn't saying much yet about its minimally invasive technology for varicose veins, other than it is designed to trigger spasms in the endothelium of the diseased vein in conjunction with the delivery of a sclerosant, a chemical irritant that will further disrupt the vessel wall. This one-two punch will cause veins to stenose very rapidly without risk to surrounding tissues, the company claims, enabling a fast, pain-free procedure in an outpatient setting

Related Content

Topics

Related Companies

Related Deals

UsernamePublicRestriction

Register

MT037431

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel